These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2958303)

  • 1. Heparan sulfate and heparin as a potentiator or a suppressor of growth of normal and transformed vascular endothelial cells.
    Imamura T; Mitsui Y
    Exp Cell Res; 1987 Sep; 172(1):92-100. PubMed ID: 2958303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro.
    Mueller SN; Thomas KA; Di Salvo J; Levine EM
    J Cell Physiol; 1989 Sep; 140(3):439-48. PubMed ID: 2777882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated glycosaminoglycans modify growth factor-induced neurite outgrowth in PC12 cells.
    Damon DH; D'Amore PA; Wagner JA
    J Cell Physiol; 1988 May; 135(2):293-300. PubMed ID: 2967302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors.
    Westergren-Thorsson G; Persson S; Isaksson A; Onnervik PO; Malmström A; Fransson LA
    Exp Cell Res; 1993 May; 206(1):93-9. PubMed ID: 7683278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor.
    Gordon PB; Choi HU; Conn G; Ahmed A; Ehrmann B; Rosenberg L; Hatcher VB
    J Cell Physiol; 1989 Sep; 140(3):584-92. PubMed ID: 2528552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis.
    Fujiwara Y; Kaji T
    Toxicology; 1999 Apr; 133(2-3):147-57. PubMed ID: 10378481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.
    Olwin BB; Rapraeger A
    J Cell Biol; 1992 Aug; 118(3):631-9. PubMed ID: 1379245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin.
    Sudhalter J; Folkman J; Svahn CM; Bergendal K; D'Amore PA
    J Biol Chem; 1989 Apr; 264(12):6892-7. PubMed ID: 2708348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans enhance human leukemic cell growth in vitro.
    Maurer AM; Han ZC; Dhermy D; Brière J
    Leuk Res; 1994 Nov; 18(11):837-42. PubMed ID: 7967710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact with basement membrane heparan sulfate enhances the growth of transformed vascular endothelial cells, but suppresses normal cells.
    Imamura T; Tokita Y; Mitsui Y
    Cell Struct Funct; 1991 Jun; 16(3):225-30. PubMed ID: 1655288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans modulate cell-matrix interactions of human fibroblasts and endothelial cells in vitro.
    Schaefer T; Roux M; Stuhlsatz HW; Herken R; Coulomb B; Krieg T; Smola H
    J Cell Sci; 1996 Feb; 109 ( Pt 2)():479-88. PubMed ID: 8838671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate enhances growth of transformed human cells.
    Matuoka K; Mitsui Y; Murota S
    Cell Struct Funct; 1984 Dec; 9(4):357-67. PubMed ID: 6241504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin induces changes in the synthesis of porcine aortic endothelial cell heparan sulfate proteoglycans.
    Morrison P; Lowe-Krentz LJ
    Exp Cell Res; 1989 Oct; 184(2):304-15. PubMed ID: 2530099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfation-dependent down-regulation of interferon-gamma-induced major histocompatibility complex class I and II and intercellular adhesion molecule-1 expression on tubular and endothelial cells by glycosaminoglycans.
    Yard BA; Lorentz CP; Herr D; van der Woude FJ
    Transplantation; 1998 Nov; 66(9):1244-50. PubMed ID: 9825824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells.
    Marsh NA; Minter AJ; Chesterman CN
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):133-8. PubMed ID: 1966669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells.
    Nugent MA; Karnovsky MJ; Edelman ER
    Circ Res; 1993 Dec; 73(6):1051-60. PubMed ID: 8222077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth of normal human keratinocytes and fibroblasts in serum-free medium is stimulated by acidic and basic fibroblast growth factor.
    Shipley GD; Keeble WW; Hendrickson JE; Coffey RJ; Pittelkow MR
    J Cell Physiol; 1989 Mar; 138(3):511-8. PubMed ID: 2466852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.
    Bashkin P; Doctrow S; Klagsbrun M; Svahn CM; Folkman J; Vlodavsky I
    Biochemistry; 1989 Feb; 28(4):1737-43. PubMed ID: 2541764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.